Trials / Completed
CompletedNCT00691769
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Wake Forest University · Academic / Other
- Sex
- Female
- Age
- 30 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.
Detailed description
This is a single-center study, designed to evaluate the expression of Fas protein in skin biopsies of patients with scarring alopecia including fourteen patients with central centrifugal scarring alopecia (CCSA), three patients with lichen planopilaris (LP) and three patients with discoid lupus erythematosus (DLE). Skin biopsies of five healthy participants will be used as controls.
Conditions
Timeline
- Start date
- 2006-04-26
- Primary completion
- 2012-11-26
- Completion
- 2012-11-26
- First posted
- 2008-06-05
- Last updated
- 2018-07-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00691769. Inclusion in this directory is not an endorsement.